FDA Orange Book

Is there a generic for Rukobia?

Rukobia contains fostemsavir. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Rukobia (fostemsavir). The Orange Book shows its last listed patent expires July 13, 2029.

Run it in Rivvi

Map Rukobia and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Rukobia products in the Orange Book

Rukobia products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, extended release, oralEQ 600MG BASEMarketed (Rx)None0None

NDA 212950, held by VIIV HEALTHCARE CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Rukobia patents

Patents listed for Rukobia
PatentExpiresCoversUse codeNDA
7745625November 19, 2027Drug substanceNone212950
8168615July 13, 2029Drug productNone212950

Rukobia NDC codes

Questions

Is there a generic for Rukobia?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Rukobia (fostemsavir). The Orange Book shows its last listed patent expires July 13, 2029.

What is the generic name for Rukobia?

The active ingredient in Rukobia is fostemsavir, per the FDA Orange Book.

When does the Rukobia patent expire?

The last patent listed for Rukobia in the Orange Book expires July 13, 2029. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Rukobia and Fostemsavir

Try it on your own data today.

Free to start. Most teams are using it the same day.